2BB score and signals
iBio, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 15 | Very Low |
| Momentum | 43 | Stable |
| Financial strength | 17 | Very Weak |
| Quality | 40 | Normal |
| Risk | 46 | Moderate |
2BBBullish & Bearish
iBio, Inc. (IBIO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 24 out of 100.
iBio, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 15 | Very Low |
| Momentum | 43 | Stable |
| Financial strength | 17 | Very Weak |
| Quality | 40 | Normal |
| Risk | 46 | Moderate |
| Founded | 2008 |
| Employees | 20 |
| 52-week range | $0.66 – $3.82 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-08 | — | -0.0782 | — | $0.00 |
| 2026-11-10 | — | -0.0816 | — | $0.00 |
| 2026-09-03 | — | -0.065 | — | $58,282.00 |
| 2026-05-12 | -0.07 | -0.0639 | $0.00 | $20,400.00 |